{"id":62231,"date":"2024-12-30T10:52:12","date_gmt":"2024-12-30T10:52:12","guid":{"rendered":"https:\/\/biomedpharmajournal.org\/?p=62231"},"modified":"2025-01-06T18:55:10","modified_gmt":"2025-01-06T18:55:10","slug":"exploring-the-in-vitro-antidiabetic-efficacy-of-50-ethanolic-extract-of-acmella-ciliata-and-its-phytochemical-studies","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol17no4\/exploring-the-in-vitro-antidiabetic-efficacy-of-50-ethanolic-extract-of-acmella-ciliata-and-its-phytochemical-studies\/","title":{"rendered":"Exploring the in Vitro Antidiabetic Efficacy of 50% Ethanolic Extract of Acmella Ciliata and its Phytochemical Studies"},"content":{"rendered":"\n

Introduction<\/strong><\/p>\n\n\n\n

Diabetes is defined as elevated blood sugar levels bringing deficiencies in insulin production due to diabetes chronic hyperglycemia (HG) linked to long-term harmful effects of some chemicals and malfunction. Diabetes’s long-term effects include retinopathy the potential of blinding someone’s nephropathy condition container leading to kidney fringe neuropathy causing bottom ulcers removals besides Charcot’s & autonomic neuropathy manifest CV and sexual function1<\/sup>. CVS is, an outlying route besides more corporate voguish patients through DM. People with diabetes frequently have problems with lipoprotein metabolism and hypertension. The cause of the other, far more common caring DM T2 combination was insufficient insulin secretory response & resistance action. Under the latter group, there may be a prolonged duration of hyperglycemia without any clinical symptoms enough to induce pathologic and functional alterations in different target tissues before diabetes is identified2<\/sup>. Depending on the severity of the underlying medical condition, the level of hyperglycemia may fluctuate over time. It’s possible that a disease process exists but hasn’t advanced to the point where it can lead to hyperglycemia5<\/sup>. This kind of diabetes, previously stated as DM affects only 5\u201310% of people through DM. It remains instigated through the autoimmune demise of \u03b2-cells. Autoantibodies against insulin, islet cells GAD65 & tyrosine phosphatases IA-2 assortments obtainable indicators immunological destruction \u03b2-cell fasting hyperglycemia paramount notorious 85\u201390% people unique additional autoantibodies pace \u03b2-cell forfeiture diabetes diverges prominently occurring quickly voguish some people & slowly trendy others3<\/sup>. Ketoacidosis (KA) initial sign sickness convinced patients, especially trendy fledgling patients. Others have mild hyperglycemia during fasting, which, in the event of an infection or other stressor, container hurriedly evolvement severe HG & KA. Others, especially adults, might have enough \u03b2-cell function left behind to avoid KA for many years; these people eventually become insulin-dependent and are susceptible to KA. Extensive research efforts towards tailored therapeutics have coincided with the growing realization of the necessity for a personalized diagnosis. Patients can now access novel approaches to better insulin-mediated glycemic control, and pre-clinical models and human studies are demonstrating the promise of flesh relocates, and hereditary amendment besides several enduring subgroups. The most popular method of treating type 1 diabetes involves doing blood sugar tests by hand and then repeatedly injecting insulin subcutaneously INS pumps are utilized as an alternative to conventional injections. With the development of the artificial pancreas, the custom incessant INS infusion besides incessant checking reached a dissimilar notch. People through container attain enhanced glycaemic outcomes besides lessening draining personality control by using a CGM connected to an implanted insulin pump via a control algorithm4<\/sup>. Finding additional medications that can be used in conjunction with INS towards subordinate overexcited HG & enhance variables deprived raising side proceedings has been a focus of insulin replacement therapy. GLP-RAs together can lower the amount of daily bolus insulin needed and enhance glucose regulation. DPP-4 is an enzyme that works in a closed-loop system to prevent GLP-1 from being inactivated and to lower blood glucose levels after meals7<\/sup>. Sodium-glucose co-transporter inhibitors have been linked to better glucose regulation and a decreased incidence of hypoglycemia episodes by requiring less insulin. While conventional and combination slants INS rehabilitation are still valuable apparatuses management of type 1 diabetes, they are not remedied & achieve the degree of control required to prevent enduring consequences of the disease. Gene therapy is a therapeutic approach to treat diseases by transferring or modifying genetic materials within the cell. The goal is to correct defective genes responsible for the advancement of the disease, either preventing the disease from starting or reversing its development.To conduct the in vitro antidiabetic study of the entire Acmella ciliata<\/em> plant, the following steps were carried out:<\/p>\n\n\n\n

Authentication.<\/p>\n\n\n\n

Extract Preparation.<\/p>\n\n\n\n

Phytochemical analysis of the plant extract.<\/p>\n\n\n\n

Evaluation of antioxidant activity through:<\/p>\n\n\n\n

DPPH\n<\/p>\n\n\n\n

H\u2082O\u2082<\/p>\n\n\n\n

FRAP<\/p>\n\n\n\n

In vitro antidiabetic activity:<\/p>\n\n\n\n

Assessment cultured L6 cells5<\/sup>.<\/p>\n\n\n\n

Materials and Methods<\/strong><\/p>\n\n\n\n

Authentication<\/strong><\/p>\n\n\n\n

The plant was authenticated as Acmella ciliata<\/em> (kunth) cass. By Dr\nMinoo Divakaran, Professor, Department of Botany, Providence Women\u2019s College,\nKozhikode<\/p>\n\n\n\n

Extraction<\/strong><\/p>\n\n\n\n

Extraction of Acmella ciliata whole\nplant was carried out by cold maceration extraction.1000 grams of dried and\nfinely powdered plant material and 1500 ml of extraction solvent (Ethanol)\nwashed. After completion of extraction excess solvent was evaporated and the\ndried extract was stored by covering it with aluminium foil. The percentage yield\nof extract was found using the following formula6,<\/sup><\/p>\n\n\n\n

Percentage yield (%) = (Weight of extract \/ Weight of plant material taken) \u00d7 100.<\/p>\n\n\n\n

Phytochemical Screening7<\/sup><\/strong><\/p>\n\n\n\n

Investigation Alkaloids<\/strong><\/p>\n\n\n\n

Dragendroff\u2019s<\/strong><\/p>\n\n\n\n

Excerpt remained treated through Dragendroff\u2019s (potassium bismuth iodide). Formation carroty chocolate hurried. <\/p>\n\n\n\n

Hager\u2019s<\/strong><\/p>\n\n\n\n

Separate remained treated through Hager’s immersed picric acid. Materialization yellow shaded encourage.<\/p>\n\n\n\n

Mayer\u2019s<\/strong><\/p>\n\n\n\n

Mayer’s potassium mercuric iodide remained aid treat extracts.<\/p>\n\n\n\n

Wagner\u2019s<\/strong><\/p>\n\n\n\n

Iodine potassium remained a charity treatment extract resulting formation reddish-brown precipitate.<\/p>\n\n\n\n

Examination Carbohydrates<\/strong><\/p>\n\n\n\n

Molisch<\/strong><\/p>\n\n\n\n

Naphthol in 95 per cent ethanol remained the treated extract besides scarce drips Conc H2SO4 remained added through sides of specified indicated violet ring junction.<\/p>\n\n\n\n

 Fehling\u2019s<\/strong><\/p>\n\n\n\n

Both copper sulfate + sodium potassium tartrate remained luxury trifling portion extract before heated Red precipitate indicated.<\/p>\n\n\n\n

Barfoed\u2019s Test<\/strong><\/p>\n\n\n\n

Glacial acetic acid besides copper acetate, remained recycled extract before the heated precipitate’s red color.<\/p>\n\n\n\n

Benedict\u2019s Test<\/strong><\/p>\n\n\n\n

Copper sulfate, sodium citrate, and sodium carbonate, used to treat extract heated for ten minutes red shaded accelerate in the container. <\/p>\n\n\n\n

Assessments of proteins and Amino Acids<\/strong><\/p>\n\n\n\n

 Biuret<\/strong><\/p>\n\n\n\n

1% CuSO4<\/sub> solution besides 10% NaOH remained extracted. An assortment of thriving colours from pink to violet.<\/p>\n\n\n\n

Millon\u2019s<\/strong><\/p>\n\n\n\n

Specified reactants 5 ml stayed extract+ heated, white precipitate turns brick red or dissolves to a red colour<\/p>\n\n\n\n

Check flavonoids<\/strong><\/p>\n\n\n\n

Ferric Chloride Test<\/strong><\/p>\n\n\n\n

Extract + ferric chloride =blackish blue colour <\/p>\n\n\n\n

Lead acetate Test<\/strong><\/p>\n\n\n\n

Excerpt+ lead acetate =yellow precipitate <\/p>\n\n\n\n

 Test for Saponins<\/strong><\/p>\n\n\n\n

Foam; 2ml water besides 0.5 gm extract remained vigorously shaken foam produced persists for ten minutes.<\/p>\n\n\n\n

Antioxidant Activity Screening Methods8<\/sup><\/strong><\/p>\n\n\n\n

DPPH\nAssay<\/strong><\/p>\n\n\n\n

The DPPH progressive looking-through\nmeasure was performed & demonstrated by the methodology portrayed. Thru a\ncouple of changes. 1.0 ml of the extract, 0.3 mM DPPH in ethanol, and 1.0 ml of\nmethanol made up the 3.0 ml reaction mixture. The plant extracts under\ninvestigation remained at 10, 20, 40, 80 besides 100 \u03bcg\/ml, respectively. After\nincubating for ten minutes in darkness, the absorbance of 517 nm was measured\nusing a calorimeter. Each experiment was replicated three times &\npercentage of inhibition was calculated formula below: <\/p>\n\n\n\n

Inhibition (%) = (A0<\/sub> \u2013 A1<\/sub>\/\nA0<\/sub> ) \u00d7 100<\/p>\n\n\n\n

Where;<\/p>\n\n\n\n

o A0<\/sub>\nis the absorbance of control (containing all reagents except the test sample)<\/p>\n\n\n\n

o A1<\/sub>\nis the absorbance of the test.<\/p>\n\n\n\n

The half maximal inhibitory\nconcentration (IC 50 ) of the extracts was computed from a plot of the percentage\nof DPPH free radical inhibition versus the extract concentration.<\/p>\n\n\n\n

H\n2<\/sub>O2<\/sub>  assay9<\/sup><\/strong><\/p>\n\n\n\n

The hydrogen peroxide extremist\nrummaging examination proceeded according strategy depicted by Chanda &\nDave through minor changes. One ml excerpt five dissimilar Conc\n10,20,40,80,100\u03bcg\/ml voguish distilled water remained added two ml hydrogen\nperoxide in phosphate buffer. After 10 minutes absorbance compared to blank\nsolution containing phosphate buffer without hydrogen peroxide concentration was\ndetermined by taking absorbance at 230 nm calorimeterically. Following the aforementioned\nformula percentage of hydrogen peroxide scavenging was calculated10<\/sup><\/p>\n\n\n\n

FRAP assay10.<\/sup><\/strong><\/p>\n\n\n\n

Incubate FRAP 3.6 mL + distilled\nwater 0.4 mL for five mins at 37\u00b0C. After ten minutes, mix through 80 mL\nconcentration plant excerpt. 593 nm absorbance reaction mixture remained\nmeasured. For advancement change twist five centralizations of FeSO4<\/sub>,+\n7 H2<\/sub>O(0.1, 0.4, 0.8, 1, 1.12, 1.5 mM) remained besides absorbance\nvalues assessed concerning examination courses of action11<\/sup> .<\/p>\n\n\n\n

%\nInhibition = (1-AS\/AB) X 100<\/p>\n\n\n\n

 <\/strong>Where,<\/p>\n\n\n\n

AS =\nAbsorbance of sample<\/p>\n\n\n\n

AB = Absorbance of blank<\/p>\n\n\n\n

Assurance\nof invitro glucose take-up examination on refined l6 cell line<\/strong>11<\/sup><\/strong><\/p>\n\n\n\n

The L6 rodent myoblast cell line was\nfirst acquired National Centre for Cell Sciences (NCCS), Pune, India besides\nretaining Dulbecco\u2019s modified Eagles medium, DMEM ( Sigma Aldrich, USA).<\/p>\n\n\n\n

The cell line remained refined in a 25\ncm2 tissue culture jar through DMEM enhanced through 10% FBS, L-glutamine,\nsodium bicarbonate (Merck, Germany) besides anti-toxin arrangement containing:\nPenicillin 100U\/ml Streptomycin 100\u00b5g\/ml Amphotericin B 2.5\u00b5g\/ml humidified 5%\nCO2<\/sub> incubator cultured cell lines remained kept 37o<\/sup>C.<\/p>\n\n\n\n

In complete aseptic conditions cells\nremained passaged T flasks subsequently being trypsinized for two minutes with\n500 l of 0.025% Trypsin PBS\/0.5mM EDTA (Invitrogen). The cells remained subcultured\non 24 well plates kept for 24 hours voguish DMEM without glucose later attaining\n80 percent confluency. Test stood added developed cells last convergence\n12.5\u00b5g\/mL,25\u00b5g\/mL besides 50\u00b5g\/mL stock arrangement 1mg\/mL besides hatched 24\nhours DMEM containing 300mM glucose. Additionally, high-glucose untreated\ncontrol remained maintained. Subsequently incubation, cells remained separated\nby spinning for ten minutes at 6000 rpm. Supernatant remained disposed of 200\u00b5l\ncell lysis cradle (1MTris Hcl, 0.25M EDTA, 2M NaCl, 0.5% Triton) added. The\nhatching remained finished at 30 minutes 4\u00b0C besides glucose assessed utilizing\nhigh responsiveness glucose oxidase strategy (Coral Clinical Frameworks: Lot\nNo; RGLU1091). All trials remained rehashed voguish cliques three and mean\nnormal remained utilized estimations.<\/p>\n\n\n\n

Total Glucose in mg\/dL =   Abs-Test\/Abs \u2013\nControl \u00d7100                            <\/p>\n\n\n\n

% Glucose uptake =OD –\nTest-Standard\/OD Control  X 100<\/p>\n\n\n\n

Results and Discussion<\/strong><\/p>\n\n\n\n

 The percentage Yield of Extract<\/strong><\/p>\n\n\n\n

A sticky resinous extract was\nproduced by cold macerating the powdered plant material.<\/p>\n\n\n\n

 The amount of extract: 60.39g Weight of the\nplant material taken: 1 kilogram Percentage yield (percentage) =  (60.39 \/ 1000) \u00d7100 = 6.039%<\/p>\n\n\n\n

 Phytochemical Screening<\/strong>13<\/sup><\/strong><\/p>\n\n\n\n

The\npositive results of all four alkaloid tests\u2014Dragendroff, Hager, Mayer, and\nWagner\u2014indicate that the plant extract contains a significant amount of\nalkaloids. The Dragendroff Hager’s Mayer’s & Wagner’s were positive for all\nwhich indicated favourable phyto constituents were present in the extract\nagainst the treatment of diabetes mellitus.  Alkaloids exist as sundry assemblage organic\ncompounds that are found voguish besides mostly consist of basic nitrogen\natoms. They have properties that are analgesic, antimalarial, antibacterial,\nand anticancer, among other pharmacological activities. The presence of\nalkaloids in this plant suggests it might have expected restorative\napplications in treating different sicknesses. Molisch Carbohydrate Test: Test\nof Positive Fehling: The Test of Positive Barfoed: Benedict’s Positive Test:\nPositive The positive results of the tests performed by Molisch, Fehling,\nBarfoed, and Benedict demonstrate that the plant extract contains\ncarbohydrates. Carbohydrates are essential to the metabolism of plants and can\nalso have therapeutic effects like providing energy, strengthening the immune\nsystem, and reducing inflammation. The presence of carbohydrates suggests that\nthe plant may provide additional health benefits and be an excellent natural energy\nsource. Biuret Test: Test Negative by Millon: Negative The absence of\nsignificant amounts of proteins or amino acids in the plant extract is\nsuggested by the negative results of both the Biuret and Millon tests. Proteins\nand amino acids are necessary for numerous physiological processes, such as the\nactivity of enzymes and tissue repair. Their nonappearance demonstrates that\nwhile the plant may not be a critical wellspring of these macromolecules, it\nmay as yet have other bioactive mixtures adding to its restorative properties.\nTest of Flavonoids and Tannins with Ferric Chloride: Positive Test for Lead\nAcetate: Positive The positive outcomes for both Ferric Chloride and Lead\nAcetic acid derivation assessments illustrate the existence of flavonoids besides\ntannins. Flavonoids condense risk-enduring sicknesses resembling malignance association\nof antioxidant properties. Tannins have astringent properties and are known for\ntheir capacity to accelerate proteins, making them helpful in treating wounds\nand irritation13<\/sup>. These compounds may have significant antioxidant\nand anti-inflammatory properties, as suggested by their presence in the plant.\nFroth Test: Positive The positive Foam test result indicates that the plant\nextract contains saponins. Saponins are glycosides with cleanser-like\nproperties and are known for their capacity to upgrade the resistant framework,\ndiminish cholesterol levels, and show hostility to malignant growth properties.\nThe discovery of saponins suggests that the plant might be used to improve\nimmune function and other aspects of health14<\/sup>.<\/p>\n\n\n\n

Table 1: Phytochemical Screening<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Test<\/strong><\/p>\n<\/td>\n

\n

Experiment<\/strong><\/p>\n<\/td>\n

\n

Result<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Alkaloids<\/p>\n<\/td>\n

\n

Dragendroff\u2019s<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Hager<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Mayer<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Wagner<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Carbohydrate<\/p>\n<\/td>\n

\n

Molisch<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Fehlings<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Barfoed<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Benedict<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Protein and amino acid<\/p>\n<\/td>\n

\n

Biuret<\/p>\n<\/td>\n

\n

–<\/p>\n<\/td>\n<\/tr>\n

\n

Millon<\/p>\n<\/td>\n

\n

–<\/p>\n<\/td>\n<\/tr>\n

\n

Flavanoid and Tanin<\/p>\n<\/td>\n

\n

Ferric chloride<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Lead acetate<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n

\n

Saponin<\/p>\n<\/td>\n

\n

Foam<\/p>\n<\/td>\n

\n

+<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n

In-Vitro Antioxidant Assays<\/strong><\/p>\n\n\n\n

DPPH<\/strong><\/p>\n\n\n\n

At various\nlevels, the solution’s concentration was measured: 10, 20, 40, 80, and 100\nmg\/ml, respectively. The following were the absorbance values that were\nrecorded for each concentration:<\/p>\n\n\n\n

At 10\nmg\/ml, the absorbance values were 0.088, 0.086, and 0.087, with a typical\nabsorbance of 0.0873 and a rate hindrance of 2.2471 \u00b1 0.5618.<\/p>\n\n\n\n

With an\naverage absorbance of 0.0836 and a percentage inhibition of 8.6141  0.5618 at 20 mg\/ml, the absorbance values\nwere 0.081, 0.083, and 0.080.<\/p>\n\n\n\n

With an\naverage absorbance of 0.0743 and a percentage inhibition of 16.4793  7.3033 absorbance standards remained 0.078,\n0.074, and 0.071.<\/p>\n\n\n\n

With an\naverage absorbance of 0.0643 and a percentage inhibition of 27.7152  2.247 at 80 mg\/ml, the absorbance values were\n0.064, 0.069, and 0.060.<\/p>\n\n\n\n

At 100\nmg\/ml, the absorbance values were 0.058, 0.052, and 0.049, with a typical\nabsorbance of 0.053 and a rate hindrance of 40.4494 \u00b1 5.0562.<\/p>\n\n\n\n

Free\nrevolutionaries are profoundly shaky substances harming dissimilar specks by\nremoving them to accomplish soundness. The endogenous antioxidant enzyme system\nregulates free radicals; however, excessive assembly unrestricted extremists glitch\ndefence mechanisms harm cells and cause a variety of diseases. Disclosure of\nregular cancer prevention agents is vital to lessen the gamble of persistent\ninfections. The cell reinforcement action of concentrate was researched beside dissimilar\nsubsequently, unrestricted revolutionaries stand of various synthetic element\nit is crucial for test the concentrate against many free extremists to\ndemonstrate its cell reinforcement movement. As a result, numerous in-vitro\nmethods were utilized for screening IC50 values of 107mg\/ml. The\nantioxidant-induced decrease in 519 nm was used to determine the DPPH radical’s\ncapacity reduction. The results show that the DPPH diverges through bout\nascorbic acid standards were utilized & assessed dissimilar concentrations.\nThe results are summarized as follows\n10 \u03bcg\/mL absorbance\nvalues recorded stayed 0.099, 0.096, besides 0.097, with an average absorbance\nof 0.09733. The corresponding percentage inhibition of DPPH radicals was 3.24 \u00b1\n0.5618%. 20 \u03bcg\/mL, the absorbance values recorded remained\n0.082, 0.093 besides 0.090, with an average absorbance of 0.088333. The\npercentage inhibition at this concentration was 10.61 \u00b1 0.5618%. 40 \u03bcg\/mL absorbance values stayed at 0.079, 0.094 besides 0.091, with\nan average absorbance of 0.088 percentage inhibition was 17.47 \u00b1 7.3033%. 80 \u03bcg\/mL absorbance values stood at 0.065, 0.079, besides 0.070,\naverage absorbance of 0.07133. The percentage inhibition is 37.7152 \u00b1 2.247%. 100 \u03bcg\/mL, absorbance values 0.068, 0.062, and 0.059, thru an average\nabsorbance of 0.063. The corresponding percentage inhibition was 50.4494 \u00b1\n5.0562%. The IC50 value, representing ascorbic acid obligatory inhibits 50% DPPH\nradicals determined at 112 \u03bcg\/mL. Consequences designate possible ascorbic acid\nwhich exhibits a dose-dependent increase in free radical scavenging activity.<\/p>\n\n\n\n

Table 2: DPPH  Scavenging Examine Extract<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Conc <\/strong>(\u03bcg\/ml)<\/strong><\/p>\n<\/td>\n

\n

Abs<\/strong><\/p>\n<\/td>\n

\n

%\u00a0 Inhibition<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

A1<\/strong><\/p>\n<\/td>\n

\n

A2<\/strong><\/p>\n<\/td>\n

\n

A3<\/strong><\/p>\n<\/td>\n

\n

Average<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

0.088<\/p>\n<\/td>\n

\n

0.086<\/p>\n<\/td>\n

\n

0.087<\/p>\n<\/td>\n

\n

0.0873<\/p>\n<\/td>\n

\n

2.2471\u00b10.5618<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

0.081<\/p>\n<\/td>\n

\n

0.083<\/p>\n<\/td>\n

\n

0.080<\/p>\n<\/td>\n

\n

0.0836<\/p>\n<\/td>\n

\n

8.6141\u00b10.5618<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

0.078<\/p>\n<\/td>\n

\n

0.074<\/p>\n<\/td>\n

\n

0.071<\/p>\n<\/td>\n

\n

0.0743<\/p>\n<\/td>\n

\n

16.4793\u00b17.3033<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

0.064<\/p>\n<\/td>\n

\n

0.069<\/p>\n<\/td>\n

\n

0.060<\/p>\n<\/td>\n

\n

0.0643<\/p>\n<\/td>\n

\n

27.7152\u00b12.247<\/p>\n<\/td>\n<\/tr>\n

\n

100<\/p>\n<\/td>\n

\n

0.058<\/p>\n<\/td>\n

\n

0.052<\/p>\n<\/td>\n

\n

0.049<\/p>\n<\/td>\n

\n

0.053<\/p>\n<\/td>\n

\n

40.4494\u00b15.0562<\/p>\n<\/td>\n<\/tr>\n

\n

120<\/p>\n<\/td>\n

\n

0.059<\/p>\n<\/td>\n

\n

0.053<\/p>\n<\/td>\n

\n

0.050<\/p>\n<\/td>\n

\n

0.054<\/p>\n<\/td>\n

\n

41.4494\u00b15.076<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Absorbance of control (A0) = 0.089<\/p>\n

Percentage inhibition = (A0<\/sub>-A1<\/sub>)\/A0 x100<\/p>\n\n\n\n
\"\"<\/td>\n\n

Figure 1: DPPH\u00a0 antioxidant activity of Extract<\/strong><\/p>\n<\/p>\n

Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n

Table 3: DPPH Scavenging Assay of  Standard<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Concentration (\u03bcg\/Ml)<\/strong><\/p>\n<\/td>\n

\n

Absorbance<\/strong><\/p>\n<\/td>\n

\n

%  Inhibition<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

A1<\/strong><\/p>\n<\/td>\n

\n

A2<\/strong><\/p>\n<\/td>\n

\n

A3<\/strong><\/p>\n<\/td>\n

\n

AVERAGE<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

0.099<\/p>\n<\/td>\n

\n

0.096<\/p>\n<\/td>\n

\n

0.097<\/p>\n<\/td>\n

\n

0.09733<\/p>\n<\/td>\n

\n

3.24\u00b10.5618<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

0.082<\/p>\n<\/td>\n

\n

0.093<\/p>\n<\/td>\n

\n

0.090<\/p>\n<\/td>\n

\n

0.088333<\/p>\n<\/td>\n

\n

10.61\u00b10.5618<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

0.079<\/p>\n<\/td>\n

\n

0.094<\/p>\n<\/td>\n

\n

0.091<\/p>\n<\/td>\n

\n

0.088<\/p>\n<\/td>\n

\n

17.47\u00b17.3033<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

0.065<\/p>\n<\/td>\n

\n

0.079<\/p>\n<\/td>\n

\n

0.070<\/p>\n<\/td>\n

\n

0.07133<\/p>\n<\/td>\n

\n

37.7152\u00b12.247<\/p>\n<\/td>\n<\/tr>\n

\n

100<\/p>\n<\/td>\n

\n

0.068<\/p>\n<\/td>\n

\n

0.062<\/p>\n<\/td>\n

\n

0.059<\/p>\n<\/td>\n

\n

0.063<\/p>\n<\/td>\n

\n

50.4494\u00b15.0562<\/p>\n<\/td>\n<\/tr>\n

\n

120<\/p>\n<\/td>\n

\n

0.078<\/p>\n<\/td>\n

\n

0.072<\/p>\n<\/td>\n

\n

0.069<\/p>\n<\/td>\n

\n

0.073<\/p>\n<\/td>\n

\n

60.494\u00b15.0623<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IC50<\/sub> = 112 mg\/ml<\/p>\n\n\n

H 2<\/sub>O2<\/sub>  assay<\/strong> <\/p>\n\n\n\n

Since isn’t very reactive on its own, it does\nproduce hydroxyl radicals in cells of A. ciliata extract might be responsible for\nscavenging hydrogen peroxide. The concentration of the solution was measured at\nseveral different levels 10-100 \u03bcg\/ml, respectively. These are the absorbance\nvalues that were recorded for every fixation:  \nWith a typical absorbance of 0.772 and a rate restraint of 3.0447 0.1855\nat 10 mg\/ml, the absorbance values were 0.782, 0.795, and 0.779.   With a typical absorbance of 0.650 and a\nrate restraint of 21.1108 0.4936, the absorbance values at 20 mg\/ml were 0.643,\n0.639, and 0.635.   At 40 mg\/ml, the\nabsorbances were 0.558, 0.571, and 0.565, respectively, with an average\nabsorbance of 0.564 and a percentage inhibition of 30.2879 0.4321. At 80 mg\/ml,\nthe absorbance values were 0.457, 0.463, and 0.462, respectively, with an\naverage absorbance of 0.4606 and a percentage inhibition of 43.1275\n0.3086.   At 100 mg\/ml, the absorbance\nvalues were 0.276, 0.283, and 0.269, respectively, with an average absorbance\nof 0.276 and a percentage inhibition of 65.7201 0.4321. The control (A0) had an\nabsorbance of 0.81 and extract IC50 of 88 g\/ml. Ascorbic acid assessed\nresults as follows: At 10 \u03bcg\/mL,\nthe average absorbance was 0.872, with a percentage inhibition of 13.0447 \u00b1\n0.2%. At 20 \u03bcg\/mL, the average\nabsorbance was 0.750, with a percentage inhibition of 31.1108 \u00b1 0.5%. At 40 \u03bcg\/mL, the average absorbance\nwas 0.664, with a percentage inhibition of 41.2879 \u00b1 0.5%. At 80 \u03bcg\/mL, the average absorbance\nwas 0.5606, with a percentage inhibition of 53.1275 \u00b1 0.4%. These results\ndemonstrate the dose-dependent hydrogen peroxide radical scavenging potential\nof ascorbic acid IC50 of 95 \u03bcg\/ml.<\/p>\n\n\n\n

Table 4: H 2<\/sub>O2<\/sub>  assay<\/strong> Extract<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n

 <\/p>\n

 <\/strong>Concentration(\u03bcg\/ml)<\/strong><\/p>\n<\/td>\n

\n

 <\/p>\n

 Absorbance<\/strong><\/p>\n

 <\/p>\n<\/td>\n

\n

 <\/p>\n

% Inhibition<\/strong><\/p>\n

 <\/p>\n<\/td>\n<\/tr>\n

\n

A1<\/strong><\/p>\n<\/td>\n

\n

A2<\/strong><\/p>\n<\/td>\n

\n

A3<\/strong><\/p>\n<\/td>\n

\n

Average<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

0.782<\/p>\n<\/td>\n

\n

0.795<\/p>\n<\/td>\n

\n

0.779<\/p>\n<\/td>\n

\n

0.772<\/p>\n<\/td>\n

\n

3.0447\u00b10.1855<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

0.643<\/p>\n<\/td>\n

\n

0.639<\/p>\n<\/td>\n

\n

0.635<\/p>\n<\/td>\n

\n

0.650<\/p>\n<\/td>\n

\n

21.1108\u00b10.4936<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

0.558<\/p>\n<\/td>\n

\n

0.571<\/p>\n<\/td>\n

\n

0.565<\/p>\n<\/td>\n

\n

0.564<\/p>\n<\/td>\n

\n

30.2879\u00b10.4321<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

0.457<\/p>\n<\/td>\n

\n

0.463<\/p>\n<\/td>\n

\n

0.462<\/p>\n<\/td>\n

\n

0.4606<\/p>\n<\/td>\n

\n

43.1275\u00b10.3086<\/p>\n<\/td>\n<\/tr>\n

\n

100<\/p>\n<\/td>\n

\n

0.276<\/p>\n<\/td>\n

\n

0.283<\/p>\n<\/td>\n

\n

0.269<\/p>\n<\/td>\n

\n

0.276<\/p>\n<\/td>\n

\n

65.7201\u00b10.4321<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Absorbance of control (A0) = 0.810<\/p>\n

Percentage inhibition = (A0<\/sub>-A1<\/sub>)\/A0 x100<\/p>\n\n\n\n
\"\"<\/td>\n\n

Figure 2: Hydrogen Peroxide Antioxidant Activity of Extract<\/strong><\/p>\n<\/p>\n

Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n

Table 5: H 2<\/sub>O2<\/sub>  assay<\/strong> standard<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n

Concentration(\u03bcg\/ml)<\/strong><\/p>\n<\/td>\n

\n

Absorbance<\/strong><\/p>\n

 <\/p>\n<\/td>\n

\n

% Inhibition<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

A1<\/strong><\/p>\n<\/td>\n

\n

A2<\/strong><\/p>\n<\/td>\n

\n

A3<\/strong><\/p>\n<\/td>\n

\n

Average<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

0.882<\/p>\n<\/td>\n

\n

0.895<\/p>\n<\/td>\n

\n

0.879<\/p>\n<\/td>\n

\n

0.872<\/p>\n<\/td>\n

\n

13.0447\u00b10.2<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

0.743<\/p>\n<\/td>\n

\n

0.739<\/p>\n<\/td>\n

\n

0.735<\/p>\n<\/td>\n

\n

0.750<\/p>\n<\/td>\n

\n

31.1108\u00b10.5<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

0.658<\/p>\n<\/td>\n

\n

0.671<\/p>\n<\/td>\n

\n

0.665<\/p>\n<\/td>\n

\n

0.664<\/p>\n<\/td>\n

\n

41.2879\u00b10.5<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

0.557<\/p>\n<\/td>\n

\n

0.563<\/p>\n<\/td>\n

\n

0.562<\/p>\n<\/td>\n

\n

0.5606<\/p>\n<\/td>\n

\n

53.1275\u00b10.4<\/p>\n<\/td>\n<\/tr>\n

\n

100<\/p>\n<\/td>\n

\n

0.376<\/p>\n<\/td>\n

\n

0.383<\/p>\n<\/td>\n

\n

0.369<\/p>\n<\/td>\n

\n

0.376<\/p>\n<\/td>\n

\n

75.7201\u00b10.5<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IC50 <\/sub>= 95\u00b5g\/ml   <\/p>\n\n\n

 FRAP Assay<\/strong><\/p>\n\n\n\n

FRAP\nexamination revealed highly reactive reduced through oxygen superoxide. Possible\nsecondary metabolites plants’ ability to prevent the formation of nitric oxide.\nFurther rummaging action powerfulness assist thru capturing chains responses\nstarted abundance age nitric oxide hazardous human wellbeing The Ferric Ion Reducing Antioxidant Power (FRAP)\nwas measured at various concentrations: 10 \u03bcg\/ml, 20 \u03bcg\/ml, 40 \u03bcg\/ml, 80 \u03bcg\/ml,\nand 100 \u03bcg\/ml. The absorbance values and the percentage inhibition for each\nconcentration are as follows: At 10 \u03bcg\/ml, the absorbance values were 1.572,\n1.549, and 1.509, with an average absorbance of 1.543 and a percentage\ninhibition of 30.2373 \u00b1 4.639. At 20 \u03bcg\/ml, the absorbance values were 1.412,\n1.443, and 1.397, with an average absorbance of 1.417 and a percentage inhibition\nof 37.9929 \u00b1 0.9641 1.264, 1.259, besides 1.237, with an average absorbance of\n1.253 and a percentage inhibition of 45.0904 \u00b1 0.5916. At 80 \u03bcg\/ml, the\nabsorbance values were 1.123, 1.102, and 1.129, with an average absorbance of\n1.118 and a percentage inhibition of 51.0065 \u00b1 0.1318. At 100 mg\/ml, the\nabsorbance values were 0.708, 0.866, and 0.954, with an average absorbance of\n0.843 and a percentage inhibition of 65.1350 \u00b1 5.2973. The absorbance of the\ncontrol (A0) was 2.282. While ascorbic acid\ndemonstrated strong reducing power at higher concentrations, the plant extract\nshowed higher percentage inhibition at lower concentrations (10-80 \u03bcg\/mL). This\nindicates that the plant extract may possess stronger antioxidant properties at\nthese concentrations compared to ascorbic acid. However, at the highest\nconcentration (100 \u03bcg\/mL), ascorbic acid displayed slightly better inhibition\nthan the extract. The IC50<\/sub> value of ascorbic acid was also lower,\nsuggesting a higher potency in reducing ferric ions at that concentration.<\/p>\n\n\n\n

Table 6: Ferric Ion Reducing Antioxidant Power <\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n

Concentration(\u03bcg\/ml)<\/strong><\/p>\n<\/td>\n

\n

Absorbance<\/strong><\/p>\n<\/td>\n

\n

% Inhibition<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

A1<\/strong><\/p>\n<\/td>\n

\n

A2<\/strong><\/p>\n<\/td>\n

\n

A3<\/strong><\/p>\n<\/td>\n

\n

Average<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

1.572<\/p>\n<\/td>\n

\n

1.549<\/p>\n<\/td>\n

\n

1.509<\/p>\n<\/td>\n

\n

1.543333<\/p>\n<\/td>\n

\n

30.2373\u00b14.639<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

1.412<\/p>\n<\/td>\n

\n

1.443<\/p>\n<\/td>\n

\n

1.397<\/p>\n<\/td>\n

\n

1.417333<\/p>\n<\/td>\n

\n

37.9929\u00b10.9641<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

1.264<\/p>\n<\/td>\n

\n

1.259<\/p>\n<\/td>\n

\n

1.237<\/p>\n<\/td>\n

\n

1.253333<\/p>\n<\/td>\n

\n

45.0904\u00b10.5916<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

1.123<\/p>\n<\/td>\n

\n

1.102<\/p>\n<\/td>\n

\n

1.129<\/p>\n<\/td>\n

\n

1.118<\/p>\n<\/td>\n

\n

51.0065\u00b10.1318<\/p>\n<\/td>\n<\/tr>\n

\n

100<\/p>\n<\/td>\n

\n

0.708<\/p>\n<\/td>\n

\n

0.866<\/p>\n<\/td>\n

\n

0.954<\/p>\n<\/td>\n

\n

0.842667<\/p>\n<\/td>\n

\n

65.1350\u00b15.2973<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Absorbance of control (A0) = 2.282<\/p>\n

Percentage inhibition = (A0<\/sub>-A1<\/sub>)\/A0 x100<\/p>\n\n\n\n
\"\"<\/td>\n\n

Figure 3: Ferric Ion Reducing Antioxidant Power<\/strong><\/p>\n<\/p>\n

Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n

Table 7: Ferric Ion Reducing Antioxidant Power of Standard <\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n

Concentration(\u03bcg\/ml)<\/strong><\/p>\n<\/td>\n

\n

Absorbance<\/strong><\/p>\n<\/td>\n

\n

% Inhibition<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

A1<\/strong><\/p>\n<\/td>\n

\n

A2<\/strong><\/p>\n<\/td>\n

\n

A3<\/strong><\/p>\n<\/td>\n

\n

Average<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

1.672<\/p>\n<\/td>\n

\n

1.649<\/p>\n<\/td>\n

\n

1.609<\/p>\n<\/td>\n

\n

1.65<\/p>\n<\/td>\n

\n

40.2373\u00b14.639<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

1.512<\/p>\n<\/td>\n

\n

1.4543<\/p>\n<\/td>\n

\n

1.497<\/p>\n<\/td>\n

\n

1.42<\/p>\n<\/td>\n

\n

47.9929\u00b10.9641<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

1.364<\/p>\n<\/td>\n

\n

1.3359<\/p>\n<\/td>\n

\n

1.337<\/p>\n<\/td>\n

\n

1.35<\/p>\n<\/td>\n

\n

55.0904\u00b10.5916<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

1.2<\/p>\n<\/td>\n

\n

1.3<\/p>\n<\/td>\n

\n

1.229<\/p>\n<\/td>\n

\n

1.1218<\/p>\n<\/td>\n

\n

81.0065\u00b10.1318<\/p>\n<\/td>\n<\/tr>\n

\n

100<\/p>\n<\/td>\n

\n

0.808<\/p>\n<\/td>\n

\n

0.966<\/p>\n<\/td>\n

\n

1.004<\/p>\n<\/td>\n

\n

0.895<\/p>\n<\/td>\n

\n

82.1350\u00b15.2973<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IC50<\/sub> = 79mg\/ml<\/p>\n\n\n

Determination of Invitro L6  Cell Lines<\/strong><\/p>\n\n\n\n

The\nexcerpt remained measured at various levels (12.5, 25, and 50 \u00b5g\/mL), and the\ncorresponding absorbance values were recorded. At 12.5 \u00b5g\/mL, the absorbance\nwas 0.1258, resulting in a glucose level of 29.44 mg\/dL and a glucose uptake of\n27.11%. At 25 \u00b5g\/mL, the absorbance increased to 0.2131, with a glucose level\nof 49.87 mg\/dL and a glucose uptake of 56.97%. At 50 \u00b5g\/mL, the absorbance was\n0.3282, with a glucose level of 76.81 mg\/dL and a glucose uptake of 72.06%. In\ncomparison, the control had an absorbance of 0.0917, a glucose level of 21.46\nmg\/dL, and a glucose uptake of 0.00%. Consequences Invitro examination\ndemonstrates plant extract significantly enhances glucose uptake in L6 cell\nlines. The increase in glucose uptake remains unswervingly proportionate\nconcentrations of plant extract, as evidenced by the rising absorbance values\nand glucose uptake percentages.<\/p>\n\n\n\n

The nethermost\nconcentration tested was 12.5 \u00b5g\/ml the plant excerpt exhibited modest intensification\nvoguish endorsement 27.11% to the control. This suggests that even at lower\ndoses, the excerpt consumes favourable consequence glucose uptake.<\/p>\n\n\n\n

At a\nconcentration of 25 \u00b5g\/mL, the glucose uptake increased substantially to\n56.97%. This indicates a more pronounced effect of the plant extract,\nsuggesting that it enhances the cells’ ability to absorb glucose more\neffectively.<\/p>\n\n\n\n

The\nhighest concentration tested (50 \u00b5g\/mL) yielded the most significant effect,\nwith a glucose uptake of 72.06%. This result highlights the potential of the\nplant extract to significantly improve glucose uptake in the cells, which could\nbe beneficial for managing blood glucose levels. Overall, the plant extract\nappears to have a dose-dependent effect on glucose uptake, with higher\nconcentrations leading to greater glucose absorption. This suggests that the\nplant extract may contain bioactive compounds that enhance glucose uptake and\ncould potentially be used as a therapeutic agent for managing diabetes or other\nglucose-related disorders. Supplementary investigations besides mechanistic\ninvestigations, remain necessary to fully understand the efficacy and mechanism\nof action of the plant extract. Metformin exhibited a\nstronger glucose uptake across all concentrations compared to the plant\nextract. Utmost attentiveness 50 \u00b5g\/mL, metformin achieved glucose uptake at 96.4%,\nwhile the plant extract reached 72.06%. This suggests that metformin is more\neffective at enhancing glucose uptake than the plant extract under the\nconditions tested. However, the plant extract still demonstrated a considerable\nglucose uptake, indicating its potential as an antidiabetic agent, though it is\nless potent compared to metformin.<\/p>\n\n\n\n

Table 8: Glucose Uptake Assay<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Conc (\u00b5g\/mL)<\/strong><\/p>\n<\/td>\n

\n

Abs<\/strong><\/p>\n<\/td>\n

\n

\u00a0Uptake<\/strong><\/p>\n<\/td>\n

\n

% uptake<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Control<\/p>\n<\/td>\n

\n

0.0917<\/p>\n<\/td>\n

\n

21.46<\/p>\n<\/td>\n

\n

0.00<\/p>\n<\/td>\n<\/tr>\n

\n

Sample<\/p>\n<\/td>\n<\/tr>\n

\n

12.5<\/p>\n<\/td>\n

\n

0.1258<\/p>\n<\/td>\n

\n

29.44<\/p>\n<\/td>\n

\n

27.11<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

0.2131<\/p>\n<\/td>\n

\n

49.87<\/p>\n<\/td>\n

\n

56.97<\/p>\n<\/td>\n<\/tr>\n

\n

50<\/p>\n<\/td>\n

\n

0.3282<\/p>\n<\/td>\n

\n

76.81<\/p>\n<\/td>\n

\n

72.06<\/p>\n<\/td>\n<\/tr>\n

\n

Standard<\/p>\n<\/td>\n<\/tr>\n

\n

12.5<\/p>\n<\/td>\n

\n

0.3200<\/p>\n<\/td>\n

\n

75.80<\/p>\n<\/td>\n

\n

71.08<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

0.4273<\/p>\n<\/td>\n

\n

85.21<\/p>\n<\/td>\n

\n

83.8<\/p>\n<\/td>\n<\/tr>\n

\n

50<\/p>\n<\/td>\n

\n

0.5200<\/p>\n<\/td>\n

\n

97.81<\/p>\n<\/td>\n

\n

96.4<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Average OD of Standard = 0.4224 & 86.26Glucose (\u03bcg\/dL)<\/p>\n\n\n\n
\"\"<\/td>\n\n

Figure 4: Graphical representation depicting the glucose level of the sample.<\/strong><\/p>\n

Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\"\"<\/td>\n\n

Figure 5: Graphical representation depicting the percentage glucose uptake<\/strong><\/p>\n

Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n

Conclusion<\/strong><\/p>\n\n\n\n

The\nwhole plant of Acmella ciliate <\/em>was\ncollected, dried, extracted and subjected to prescribed in-vitro antioxidant\nstudies. In conclusion, consequences gotten contemporary designated\nhydroethanolic whole plant excerpt Acmella\nciliate <\/em>obligate appreciable antioxidant capacity. Hence, this container charity\nexpected causes antioxidants as they might obligate countless prominence\ntherapeutic agents slowing preventing advancement besides oxidative hassle connected\npancreatic damages inhibition towards antioxidant activity. The assay aimed to\ndetermine prospective herbal excerpt enhance uptake which is a crucial factor\nin managing diabetes. L6 cells remained treated through varying concentrations of\nherbal excerpt 12.5, 25, and 50 \u00b5g\/ml and glucose levels remained measured to assess\nthe impact of the extract on glucose uptake quantified by measuring the\nabsorbance at specific wavelengths, which correlates with glucose concentration\nin the cell culture. The in-vitro glucose uptake assay results indicate that\nthe plant extract significantly enhances glucose uptake reliant manner. The\nplant extract established clear glucose uptake, with higher concentrations\nleading to greater glucose absorption by the cells. This suggests that the\nplant extract contains bioactive compounds capable of influencing glucose\nmetabolism. Given the substantial increase in glucose uptake observed at higher\nconcentrations, the plant extract holds potential as a therapeutic agent for\nmanaging diabetes or other glucose-related disorders. Its efficacy at multiple\nconcentrations suggests a promising role in enhancing cellular glucose\nabsorption. To validate these findings, additional studies are needed,\nincluding in-vivo experiments to confirm the extract’s effectiveness and\nsafety, and mechanistic studies to elucidate the underlying mechanisms\nresponsible for the observed glucose uptake enhancement. Overall, the plant\nextract shows promise as a natural compound that could contribute to the\ndevelopment of new strategies for glucose management and diabetes treatment.<\/p>\n\n\n\n

Acknowledgment<\/strong><\/p>\n\n\n\n

We would like to\nthank JDT Islam Orphanage & Educational Institutions,( JDT Islam College of\nPharmacy Vellimadukunnu, Kozhikode) for the use of their facilities. The\nauthors are grateful to for Biogenix Research Center For Molecular Biology And Applied Science, Valiyavila,\nPO, Thirumala, Thiruvananthapuram, Kerala-695006 supporting\nthe study.<\/p>\n\n\n\n

Funding Source<\/strong><\/p>\n\n\n\n

The author(s)\nreceived no financial support for the research, authorship, and\/or publication\nof this article<\/p>\n\n\n\n

Conflict of Interests<\/strong><\/p>\n\n\n\n

The\nauthor(s) do not have any conflict of interest <\/p>\n\n\n\n

Data Availability Statement<\/strong><\/p>\n\n\n\n

This\nstatement does not apply to this article<\/p>\n\n\n\n

Ethical Statement<\/strong><\/p>\n\n\n\n

This\nresearch did not involve human participants, animal subjects, or any material\nthat requires ethical approval.<\/p>\n\n\n\n

Informed Consent Statement<\/strong><\/p>\n\n\n\n

This study did not involve human participants, and therefore, informed consent was not required.<\/p>\n\n\n\n

Clinical Trial Registration<\/strong><\/p>\n\n\n\n

This\nresearch does not involve any clinical trials<\/p>\n\n\n\n

Authors\u2019 Contribution<\/strong><\/p>\n\n\n\n

G. Nagarajaperumal: Conceptualization & Methodology<\/p>\n\n\n\n

 R. Ruby: Writing \u2013 Original Draft.<\/p>\n\n\n\n

 Asha John: Data Collection, Analysis <\/p>\n\n\n\n

 M. K Purnim: Review and Editing.<\/p>\n\n\n\n

 Krishna Prasad: Plant collection<\/p>\n\n\n\n

 Fathima Rasha: Authentication<\/p>\n\n\n\n

 Jubairiya:  Phytochemical studies<\/p>\n\n\n\n

 N,  Aswathi Suresh: Pharmacological studies<\/p>\n\n\n\n

 Anjana John: Funding Acquisition, Resources, Supervision<\/p>\n\n\n\n

References <\/strong><\/p>\n\n\n\n

    \n
  1. Choudhari A, Raina P, Deshpande M, Wali A, Zanwar A, Bodhankar S, Kaul-Ghanekar R. Evaluating the anti-inflammatory potential of Tectaria cicutaria L. rhizome extract in vitro as well as in vivo. Journal of Ethnopharmacology2013;150 (5);215\u2013222. https:\/\/doi.org\/10.1016\/j.
    CrossRef <\/a><\/li>\n\n\n\n
  2. Liu X, Yin L, Shen s, Hou Y. Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies. Genes & 722PATIL , Biomed. & Pharmacol. J, 2024; 17(2);713-724 <\/li>\n\n\n\n
  3. Alfaddagh A, Martin SS, Leucker TM, Michos ED, Blaha MJ, Lowenstein CJ, Jones SR, Toth PP. Inflammation and cardiovascular disease: From mechanisms to therapeutics. American Journal of Preventive Cardiology, 2020;21(4):100130. doi: 10.1016\/j.ajpc.2020.100130.
     CrossRef <\/a><\/li>\n\n\n\n
  4. Marriott E, Singanayagam A, El-Awaisi J. Inflammation as the nexus: exploring the link between acute myocardial infarction and chronic obstructive pulmonary disease. Frontiers in Cardiovascular Medicine,2024;11(7):202, https:\/\/ doi.org\/10.3389\/fcvm.2024.1362564
     CrossRef <\/a><\/li>\n\n\n\n
  5. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochemical Pharmacology 2020; 180(17):114147. doi: 10.1016\/j.bcp.2020.114147
    CrossRef <\/a> <\/li>\n\n\n\n
  6. van den Bosch MHJ, Blom AB, van der Kraan PM. Inflammation in osteoarthritis: Our view on its presence and involvement in disease development over the years. Osteoarthritis Cartilage 2024;32:355-364. doi: 10.1016\/j. Boca.2023.12.005
     CrossRef <\/a> <\/li>\n\n\n\n
  7. Rai SN, Birla H, Singh S, Zahra W, Patil R, Jadhav J, Rao GM, Singh SP. Mucuna pruriens protects against MPTP-intoxicated neuroinflammation in Parkinson\u2019s disease through NF-\u00eaB \/pAKT signalling pathways. Frontiers in Aging Neuroscience 2017; 19 (9) https:\/\/doi.org\/10.3389\/fnagi.2017.00421
     CrossRef <\/a> <\/li>\n\n\n\n
  8. \u00a0Nunes CdR, Barreto Arantes M, Menezes de Faria Pereira S, Leandro da Cruz L, de<\/li>\n\n\n\n
  9. Souza Passos M, Pereira de Moraes L, Vieira IJC, Barros de Oliveira D. Plants as Sources of Anti-Inflammatory Agents. Molecules, 2020;25(16):3726. https:\/\/doi.org\/10.3390\/molecules25163726
     CrossRef <\/a><\/li>\n\n\n\n
  10. Zhen J, Guo Y, Villani T, Carr S, Brendler, Mumbengegwi D, Kong AT, Simon J, Wu W. Phytochemical Analysis and Anti-Inflammatory Activity of the Extracts of the African Medicinal Plant Ximenia caffra. Journal of Analytical Methods in Chemistry. 2015,94(16);62-82 https:\/\/doi. org\/10.1155\/2015\/948262
     CrossRef <\/a> <\/li>\n\n\n\n
  11. Kumar N, Singh SK, Lal RK, Sunita Singh Dhawan An insight into dietetic and nutraceutical properties of underutilized legume: Mucunapruriens (L.) DC. Journal of Food Composition and Analysis. 2024; 129, 106095.
     CrossRef <\/a> <\/li>\n\n\n\n
  12. Abdelatty Abdelgawad, Akbar Ali Samsath Begum, Emad Mahrous Awwad, Mohammed Rafi Shaik, Mujeeb Khan, Raja Mohamed Abdul Vahith, Vijay Kotra. “Spilanthes acmella Leaves Extract for Corrosion Inhibition in Acid Medium.” 2021:7(7);1-23 doi;10.1007\/s00044-021-02759-0 <\/li>\n\n\n\n
  13. Abdullah Al Mamun, Jyotirmoy Sarker, Md. Abul Kalam Azad, Md. Ataur Rahman, Md. Mohiuddin, Mohammad Safiqul Islam, Md. Shahid Sarwar, Shamima Akter. “Antidiabetic and thrombolytic effects of ethanolic extract of Spilanthes paniculata leaves.” 2015;7(9);13-18. doi: 10.1016\/j.jep.2015.09.037 <\/li>\n\n\n\n
  14. Ahmad Nazrun Shuid, Fairus Ahmad, Isa Naina Mohamed, Norazlina Mohamed, NorHazwani Ahmad, Norfilza Mokhtar, Norliza Muhammad, Putri Ayu Jayusman, Rohanizah Abdul Rahim, Sharlina Mohamad, Vuanghao Lim, Zuratul Ain Abdul Hamid. “Potential Antioxidant and Anti-Inflammatory Effects of Spilanthes acmella and Its Health Beneficial Effects.” 2021:9(7):1-15. doi: 10.1007\/s11745-021-04677-3 <\/li>\n\n\n\n
  15. Agata Rolnik, Beata Olas. “The Plants of the Asteraceae Family as Agents in the Protection of Human Health.” 2021:10(9):1-10. doi: 10.1016\/j.plaphy.2021.01.009
     CrossRef <\/a> <\/li>\n\n\n\n
  16. Ali, M., Thompson, M., & Jones, P. “A Pilot Study on the Use of Acmella oleracea in Managing Hyperglycemia and Lipid Profiles in Diabetic Patients.” Clinical Nutrition, 38(1), 213-220. doi: 10.1016\/j.clnu.2018.01.014
     CrossRef <\/a><\/li>\n\n\n\n
  17. Bahare Salehi, Athar Ata, Nanjangud V. Anil Kumar, Farukh Sharopov, Karina Ram\u00edrez-Alarc\u00f3n, Ana Ruiz-Ortega, Seyed Abdulmajid Ayatollahi, Patrick Valere Tsouh Fokou, Farzad Kobarfard, Zainul Amiruddin Zakaria, Marcello Iriti, Yasaman Taheri, Miquel Martorell, Antoni Sureda, William N. Setzer, Alessandra Durazzo, Massimo Lucarini, Antonello Santini, Raffaele Capasso, Elise Adrian Ostrander, Atta -ur-Rahman, Muhammad Iqbal Choudhary, William C. Cho, and Javad Sharifi-Rad. “Antidiabetic potential of medicinal plants and their active components.” 2019:1(2)-121. doi: 10.1016\/j.jep.2018.11.002
     CrossRef <\/a> <\/li>\n\n\n\n
  18. Chang, C., and Lin, M.”Comparative Analysis of Antioxidant and Anti-Inflammatory Effects of Acmella Species: Potential Mechanisms in Diabetes Prevention.” Phytotherapy Research, 34(5),1234-1245. doi: 10.1002\/ptr.6576
     CrossRef <\/a> <\/li>\n\n\n\n
  19. Doe, J., Smith, A., & Lee, R. “Effect of Acmella oleracea Extract on Blood Glucose Levels in Type 2 Diabetic Rats.” Journal of Ethnopharmacology,2020:10(16);260-270. doi: 10.1016\/j.jep.2020.113073
     CrossRef <\/a> <\/li>\n\n\n\n
  20. Donkupar Syiem & Phibangipan Warjri. “Antidiabetic activity of TNF activity lowering properties of the plant extract Ixeris gracilis in alloxan-induced diabetic mice, Pharm.Biol,2014:4(1)1-10. doi: 10.1007\/s10753-014-9947-8<\/li>\n\n\n\n
  21. Esther Laltlanmawii, Fanai Lalsangpuii, Fanai Nghakliana, Joseph V. L. Ruatpuia, Lal Fakawmi, Ralte Lalfakzuala, Samuel Lalthazuala Rokhum, Zothan Siama. “Green Synthesis of Silver Nanoparticles Using Spilanthes acmella Leaf Extract and its Antioxidant-Mediated Ameliorative Activity against Doxorubicin-Induced Toxicity in Dalton\u2019s Lymphoma Ascites (DLA)-Bearing Mice ACS Omega, 2022:48(7):44346-44359. doi: 10.1007\/s11046-022-00799-4
    CrossRef<\/a><\/li>\n\n\n\n
  22. Andrade-Cetto, A., J. Becerra-Jimenez, and R. Cardenas-Vazquez. \u03b1-Glucosidase inhibitory activity of some Mexican plants used in the treatment of type 2 diabetes. J Ethnopharmacol, 2008: 116(18):27-32 doi: 10.1016\/j.jep.2007.10.039.<\/em>
    CrossRef <\/a> <\/li>\n\n\n\n
  23. Chang, C., M. Yang, H. Wen, and J. Chern. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal, 2010:10(3): 178-182. doi: 10.38212\/2224-6614.2748
    CrossRef <\/a> <\/li>\n\n\n\n
  24. Cotelle, A., J.L. Bernier, J.P. Catteau, J. Pommery, J.C. Wallet, and E.M. Gaydou. Antioxidant properties of hydroxyl flavones. Free Radic Biol Med,1996 20(4):35-43. doi: 10.1016\/0891-5849(95)02014-3
    CrossRef <\/a><\/li>\n\n\n\n
  25. Elmastas, M., I. Gulcin, O. Isildak, O.I. Kufreivioglu, K. Ibaoglu, and H.Y. Aboul-Enein. Radical scavenging activity and antioxidant capacity of bay leaf extracts. J Iran Chem Soc,2006:3(1):258-266. doi: 10.1007\/BF03246078
     CrossRef <\/a> <\/li>\n\n\n\n
  26. Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum. Analysis of nitrate, nitrite, and (15N) nitrate in biological fluid. Anal Biochem,2022:26(5):131-138 . doi: 10.1016\/0003-2697(82)90118-X
     CrossRef <\/a> <\/li>\n\n\n\n
  27. Gulcin, I., H.A. Alici, and M. Cesur. Determination of in vitro antioxidant and radical scavenging activities of propofol. Chem Pharm Bull,2005:53(12):281-285 doi: 10.1248\/cpb.53.281
     CrossRef <\/a><\/li>\n\n\n\n
  28. Inas, S.G., S.A. Ekram, F.B. Hoda, M.F. Ibrahim, and A.N. Somaia. Evaluation of antihyperglycemic action of Oyster Mushroom (Pleurotus ostreatus<\/em>) and its effect on DNA damage, chromosome aberrations, and sperm abnormalities in streptozotocin-induced diabetic rats. J Ethnopharmacol,,2011:7(2):532-544 doi: 10.1016\/j.jep.2011.06.038
    CrossRef <\/a> <\/li>\n\n\n\n
  29. Kunchandy, E., and M.N.A. Rao. Oxygen radical scavenging activity of curcumin. Int J Pharmacol, 2009: 58(6):237-240. doi: 10.1016\/S0020-1693(00)84884-7
     CrossRef <\/a> <\/li>\n\n\n\n
  30. Maritim, A.C., R.A. Sanders, and J.B. Watkins III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol,2003:17(3):24-38 doi: 10.1002\/jbt.10058
    CrossRef<\/a> <\/li>\n\n\n\n
  31. Mee-Jung Kim, Song-Suk Kim, and Soon-Dong Kim. Anti-diabetic effect of Red Ginseng-Chungkukjang with Green Laver or Sea Tangle. J Food Sci Nutr,2010: 15(3): 17-26. doi: 10.3746\/jfn.2010.15.1.017
     CrossRef <\/a> <\/li>\n\n\n\n
  32. Nishimiki, M., N.A. Rao, and K. Yagi. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun,1972: 46(6): 849-853. doi: 10.1016\/S0006-291X(72)80218-3
     CrossRef <\/a> <\/li>\n\n\n\n
  33. Oyaizu, M. Studies on products of browning reactions: Antioxidant activities of products of browning reaction prepared from glucose amine. Jpn J Nutr,1986: 44(5): 307-315. doi: 10.5264\/eiyogakuzashi.44.307
     CrossRef <\/a> <\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Introduction Diabetes is defined as elevated blood sugar levels bringing […]<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[119],"tags":[],"class_list":["post-62231","post","type-post","status-publish","format-standard","hentry","category-vol17no4"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/62231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=62231"}],"version-history":[{"count":5,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/62231\/revisions"}],"predecessor-version":[{"id":63545,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/62231\/revisions\/63545"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=62231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=62231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=62231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}